Illumina
ILMN
#1099
Rank
ยฃ15.26 B
Marketcap
ยฃ99.29
Share price
3.83%
Change (1 day)
-14.20%
Change (1 year)

Revenue for Illumina (ILMN)

Revenue in 2025 (TTM): ยฃ3.26 Billion

According to Illumina's latest financial reports the company's current revenue (TTM ) is ยฃ3.22 Billion. In 2024 the company made a revenue of ยฃ3.48 Billion a decrease over the revenue in the year 2023 that were of ยฃ3.53 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Illumina from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ3.26 B-6.34%
2024 ยฃ3.48 B-1.45%
2023 ยฃ3.53 B-6.68%
2022 ยฃ3.78 B12.98%
2021 ยฃ3.35 B41.1%
2020 ยฃ2.37 B-12.05%
2019 ยฃ2.70 B2.93%
2018 ยฃ2.62 B28.96%
2017 ยฃ2.03 B4.72%
2016 ยฃ1.94 B29.76%
2015 ยฃ1.49 B25.29%
2014 ยฃ1.19 B38.76%
2013 ยฃ0.86 B21.25%
2012 ยฃ0.71 B4.64%
2011 ยฃ0.67 B16.13%
2010 ยฃ0.58 B42.02%
2009 ยฃ0.41 B5.28%
2008 ยฃ0.39 B111.83%
2007 ยฃ0.18 B95.93%
2006 ยฃ94.23 M121.09%
2005 ยฃ42.62 M61.76%
2004 ยฃ26.34 M68.12%
2003 ยฃ15.67 M150.29%
2002 ยฃ6.26 M265.1%
2001 ยฃ1.71 M95.53%
2000 ยฃ0.87 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
PerkinElmer
PKI
ยฃ2.52 B-21.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacific Biosciences
PACB
ยฃ0.11 B-96.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
ยฃ5.10 B 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ32.86 B 919.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ0.16 B-94.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
ยฃ18.23 B 465.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ8.15 B 153.03%๐Ÿ‡บ๐Ÿ‡ธ USA